|
AASLD. (2012). Practice Guideline
Abdul Rehman Khan, F. R. A. (2014). Metals in the pathogenesis of type 2 diabetes. 13(1), 16. Abrams GA, K. S., Lazenby AJ, Clements RH,. (2004). Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Ahmed A, W. R., Harrison SA,. (2015). Nonalcoholic fatty liver disease review:Diagnosis, treatment, and outcomes. Clin. Gastroenterol. Hepatol., 13, 2062-2070. Akira S, T. T., Kishimoto T. (1993). Interleukin-6 in biology and medicine.Adv Immunol . AmarapurkarDN, H. E., Lesmana LA, Sollano JD, Chen PJ&, Goh KL. (2007). .How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences. J Gastroenterol Hepatol. 22, 788-793. Angulo, P. (2002). Nonalcoholic fatty liver disease. N Engl JMed. 346, 1221–1231. Angulo P, K. D., Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, . (2015). Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 149, 389–397. Angulo P, K. J., Batts KP, Lindor KD. (1999). Independent predictors of liver fibrosis in patients with nonalcoholicsteatohepatitis. Hepatology 30, 1356–1362. Ao ZH, X. Z., &Lu ZM, Xu HY,& Zhang XM, Dou WF. (2009). Niuchangchih Antrodicamphorateand its potential in treating liver diseases. J Ethnopharmacol. 121, 194–212. Appay V, v. L. R., & Sallusto F, Roederer M. (2008). Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73(11), 975–983. AR, L. C. S. (2011 ). Inflammatory links between obesity and metabolic disease.Jun. 121(6), 2111-2117. Arun J. Sanyal, M. D., Naga Chalasani, M.B., B.S., Kris V. Kowdley, M.D., Arthur McCullough, M.D.,. (2010).)Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 362, 1675–1685. Assy N, K. K., Mymin D, Levy C, &Rosser B, Minuk G. (2000). Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 45, 1929-1934. Bedossa P, P. C. V. N., et al. (2012). Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 56, 1751–1759. Bertolino P, H. W., Hardy CL, Morahan G,& Miller JF. (1995). Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur. J. Immunol. 25,42. Bloomer SA, O. A., Bergmann OM, Mathahs MM,Broadhurst KA, Hicsasmaz H &Brown KE. (2016). Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. Dec. 34(8), 628-639. Bugianesi E , L. N. V. E., et al. (2002). Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellularcarcinoma. Gastroenterology. 123, 134–140. Byrne, L. S. B. N. P. C. P. C. C. C. D., & J, E. H. (2012). Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor. 1190-1200. Call ME, P. J. W. M., Wucherpfennig KW. (2002). The organizing principle in the formation of the T cell receptor-CD3 complex.Cell. December 111 (7), 967–979. Calne RY, S. R., Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, Davies DA. (1969). Induction of immunological tolerance by porcine liver allografts. Nature 223-472. Camps J, B. T., Gimenez A, Alie S& Caballeria J, Pares A, et al. (1992). Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration. Clin Sci(Lond). 83(6), 695–700. Canadian Liver Foundation. (2015). Retrieved from Chang Js, K. H. C. K., Kong ZL. (2015). Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata. Chen-Chung Fu, M.-C. C., Yin-Ming Li, Tso-Tsai Liu,Li-Yu Wang,. (2009). The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Ann Acad Med Singap. 38, 15–17. Chen CH, H. M., Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. (2006). Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 40, 745–752. Chen CH, H. M., Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. ( 2007). Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol. 22, 1482–1489. Chen H& Zhang M, X. B. (2004). Quantification of uronic acids in tea polysaccharide conjugates and their antioxidant properties. J Agric Food Chem. 52, 3333–3336. Chia-Chi Wang, C.-S. H., Chun-Jen Liu,Jia-Horng Kao,, & Chen, D.-S. (2007). Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. 10.1111 1440-1746. Chiang Pc, L. S., Pan SL&Kuo CH, et al. (2010). Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. 15, 79(72). Chiu CC, L. W., Wang W, Lee YC, Huang MT. (2008). Correlations of laparoscopy with histology and laboratory studies on liver diseases in bariatric patients. Obes Surg. 18, 204–211. Chiu CH, P. C., Ker YB, Chen CC& Lee A, et al. (2014). Physicochemical characteristics and anti-inflammatory activities of a novel glycoprotein, antrodan, isolated fromAntrodia cinnamomeamycelia. Molecules 19, 22–40. Chiu HW, H. K. (2016). Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat., 5;11(4). Chou M. C., C. R., Hung Y. H&Chen Y. C., Chiu C. H. (2013). .Antrodia camphorata ameliorates high-fat-diet induced hepatic steatosis via improving lipid metabolism and antioxidative status.J. Funct. Foods 5, 1317–1325. DA, B. R. B. (2005). Liver fibrosis. J Clin Invest. 115, 209–218. Damas P, L. D., Nys M,Vrindts Y,De Groote D,et al. (1992). Cytokine serum levels during severe sepsis in human:IL-6 as a marker of severity.Ann Surg 215, 362-365. Day CP, J. O. (1998). Steatohepatitis: a tale of two ‘hits’ Gastroenterology 114, 842-845. De Jong RA, L. N., Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, Nijman HW. (2009). Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol. 114, 105–110. Deng Js, H. S., Lin TH&Lee MM,et al. (2013). Analgesic and anti-inflammatory bioactivities of eburicoic acid and dehydroeburicoic acid isolated from Antrodia camphorata on the inflammatory mediator expression in mice. 29, 61(21). Djenidi F, A. J., Goubar A, Durgeau A, Meurice G, de Montpreville V, Validire P&Besse B, Mami-Chouaib F. (2015). CD8+CD103 + tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. J Immunol. 194, 3475–3486. Du Plessis J, v. H., Janssen CE, Roos L, Slavik T, Stivaktas PI, et al. (2013). Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol 58, 1125–1132 Du Plessis J, v. P. J., Korf H, Mathieu C, van der Schueren B, Lannoo M, Oyen T4, Topal B, Fetter G. (2015). Association of Adipose Tissue Inflammation With Histological Severity of Non-alcoholic Fatty Liver Disease.Gastroenterology. 149, 635–648. Farrell GC, L. C. (2006). Non-alcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 43, (2 Suppl.1),S99–S112. Fiore G, G. V. P. G. (1997). CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C. Gao Q, Z. J., Wang XY, Qiu SJ, Song K, Huang XW, Sun J, Shi YH, Li BZ, Xiao YS, Fan J. (2012). Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Ann Surg Oncol. 19,, 455–466. Geng Y, W. J., Sun Q,Xle M,Lu ZM,&Xu HY,Shi Js,Xu ZH. (2016). Identification of antrodin B from Antrodia camphorata as a new anti-hepatofibrotic compound using a rapid cell screening method and biological evaluation. 46(3), E15-25. George DK, G. S., MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW. (1998). Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Getachew Y, C. F., James LP, Thiele DL. (2014). The role of intrahepatic CD3+/CD4-/CD8- double negative T (DNT) cells in enhanced acetaminophen toxicity.Toxicol Appl Pharmacol. 15,280(2), 264-271. Goc J, G. C., Vo-Bourgais TK, Lupo A, Klein C, Knockaert S, de Chaisemartin L&Ouakrim H, Becht E, Alifano M. (2014). Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8 + T cells. Cancer Res. 74, 705–715. Gokila Vani M, K. K., Liao JW&Chien SC, Mau JL. (2013). Antcin C from Antrodia cinnamomea Protects Liver Cells Against Free Radical-Induced Oxidative Stress and Apoptosis In Vitro and In Vivo through Nrf2-Dependent Mechanism.Evid Based Complement Alternat Med. 10, 11-55. Guideline, W. P. (2012). NAFLD & NASHGlobal Guide
Harrison SA, F. W., Brunt EM, Neuschwander-Tetri BA. (2009). Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. 49(1), 80-86. Hashimoto E, T. K. (2011). Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 46,(Suppl 1), 63–69. Hong F, K. W. T. Z., et al. (2002). Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene. 21, 32–43. Horiguchi N, W. L. M. P., et al. (2008). Cell type-dependent pro-and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology. 134, 1148–1158. Hsiao, T. J., Chen, J.C& Wang, J.D. (2004). Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. Int J Obes Relat Metab Disord. 28, 167–172. Huan-Wen Chiu, K.-F. H. (2016). Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat. Huang CH, C. Y., Liu CW, Kang WY, Lin YL&Chang HC, et al. (2010). Fruiting body of Niuchangchih(Antrodia camphorata) protects livers against chronic alcohol consumption damage. J Agric Food Chem. 58(6),38, 59–66. Huang HL, L. W., Lee LT, Wang HH, Lee WJ, Huang KC. (2007). Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg. 17, 1457–1463. Huang TT, W. S., Chong KY &Ojcius DM, Ko YF. (2014). The medicinal fungus Antrodia cinnamomea suppresses inflammation by inhibiting the NLRP3 inflammasome. Aug. 8.155(1), 154-164. Hui JM, K. J., Chitturi S, et al. (2003). Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38, 420–427. Jagetia GC, R. T., Venkatesha VA& Kedlaya R. (2004). Influence of naringin on ferric iron induced oxidative damage in vitro. Clinica Chimica Acta. .347(1-2), 189–197. Jia Q, Y. Y., Wan Y. (2015). Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis. Int J Clin Exp Med. 1803–1813. Jia XY, Y. W. S. Y., LiQ. (2015). Distribution of CD45RO⁺T and CD45RA⁺T Cells in Peripheral Blood of Patients with Peripheral T Cell Lymphoma. Johannie du , P., Hannelie Korf&Jos van Pelt. (2016). Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. Jung UJ, C. M. (2014). Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. 15(4), 6184-6223. Kai-Lun Shih, W.-W. S., Chia-Chu Chang, Chew-Teng Kor, Chen-Te Chou, Ting-Yu Chen & Hung-Ming Wu. (2016). Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease
Khan FA, A. J. N. A. S., et al. (2015). Comparative study of serum copper, iron, magnesium, and zinc in type 2 diabetes-associated proteinuria. Biol Trace Elem Res. 168(2), 321–329. Kim CH, K. H., Bae SJ, Park JY& Lee KU. (2011). Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 60(3), 414–420. Kindt, T. J., Goldsby, Richard A Osborne, Barbara Anne, & Kuby, J. (2007). Kuby immunology. Macmill 223– 228. Kitamura, S., T. Hori, K. Kurita, K. Takeo, C. Hara, W. Itoh, K. Tabata, A. Elasaeter& B. T. Stokke. (1994). An antitumor branched β-(1-3)-D-glucan from a water extract of fruiting bodies of Cryptoporus volvatus. Carbohydrate Research 263, 111-121. Kleiner DE, B. E. V. N. M., et al. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41, 1313–1321. Kumar KJ, C. F., Hsieh HW, Liao JW, Li WH, Lin JC, Shaw JF, Wang SY. (2011). Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activation.J Ethnopharmacol. 136(1), 168-177. Leclercq IA, F. G. F. J. e. a. (2000)). CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105, 1067–1075. Lee H-S, S. C.-T., Chiou L-L, Chen C-H, Huang G-T, Sheu J-C. (2005). Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: emphasis on sampling variability. J Gastroenterol Hepatol. 20, 1109–1114. Lee KS, B. M. H. K. e. a. ( 1995). Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96, 2461–2468. Lee SB, J. H., Lee YW, Lee YML&Song KW, et al. (2003). Bio-artificial skin composed of gelatin and (1,3), (1,6)-glucan. Biomaterials 24, 2503–2511. Limmer A, O. J. K. C. e. a. (2000). Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nature Med. 6, 1348–1354. Lin KJ, L. S., Su CH,Chiang BL,et al. (2010). Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen-induced T helper type 2 responses in a mouse model of asthma. 129(3), 351-362. Lin Yw, P. J., Lin RH,Kuo YH,et al. (2010). The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells. 15,90(10), 1739-1744. Lohse AW, K. P., Bilo K, Uhrig A, Waldmann C. (1996). Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells.Gastroenterology. 110(4), 1175-1181. Ludwig J, V. T., &McGill DB, Oh BJ. (1980). Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 55, 434–438. Lumeng CN, B. J. S. A. J. C. I. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. 117(1), 175-184. Machado MV, C.-P. H. (2013). Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatol 58, 1007-1019. Madamanchi Geethangili , Y.-M. T. (2011). Review of pharmacological effects of Antrodia camphorataand its bioactive compounds.Evid Based Complement Alternat Med. 1–17. Marchesini, G., Brizi,M.,Bianchi,G.,Tomassetti,S&Zoli,M.,Melchionda, N. (2001). Meterformin in non-alcoholic steatohepatitis. 358, 893-894. Matteoni CA, Y. Z., Gramlich T, Boparai N, Liu YC&McCullough AJ. (1999). Nonalcoholic fatty liver disease: a spectrum of clinical and pathological.severity. Gastroenterology. 116, 1413–1419. Med, E. b. C. A. (2011 ). Evid based Complement Alternat Med 43, (2 Suppl.1),S99–S112. Michie CA, M. A. A. C., Beverley PC. (1992). .Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 360, 264–265. Mojiminiyi OA, M. R., Abdella NA. (2008). Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 18(8), 559–566. Moradali MF, M. H. G. S., Hedjaroude GA (2007). Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi).Int Immunopharmacol. 7, 701–724. Mummadi RR, K. K. C. S. e. a. (2008). Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 6, 1396–1402. Murawaki Y, H. C. (1980). Hepatic collagenolytic cathepsin in patients with chronic liver disease. Clin Chim Acta. 108, 121–128. MussoG, G. C. (2013). Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid.Res. 52(1), 175-191. Nuti S, R. D. V. N. e. a. (1998). ynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28,, 3448–3455. Okada S, N. M., Mikami Y, Shimazaki T&Mihara M, Ohsugi Y, et al. (2004). Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res. 76, 265–276. Okanoue T, Y. N., Furutani M et al. (2005). Predictors of nonalcoholic steatohepatitis in Japanese patients: thioredoxin and NASH. In: OkitaK, ed. NASH and Nutritional Therapy. Tokyo: Springer. 64–72. Pages F, B. A., Camus M, Sanchez-Cabo F, Costes A, Molidor R& Mlecnik B, Kirilovsky A,& Nilsson M, Damotte D. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 353, 2654–2666. Peng CH, Y. M. Y. Y., Yu CC, Wang CJ. (2017). Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling. 45(1), 67-83. Penninger JM1, I.-S. J., Sasaki T, Oliveira-dos-Santos AJ. (2001). CD45: new jobs for an old acquaintance 2(5), 389-396. Pessayre D, F. B., Mansouri A. (2004). Mitochondrial injury in steatohepatitis. 16(11), 1095-1105. Prashanth M, G. H., Vima MV, John M, Bandgar T&Joshi SR, Shah SR, Rathi PM, Joshi AS, &Thakkar H, Menon PS, Shah NS. (2009). Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India. 57, 205-210. Promrat K, K. D. N. H. e. a. (2010). Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121–129. Qi J, T. Y., Zhang J&Fu J,et al. (2014). Effect of Antrodia cinnamomea on gene expression related to aortal endothelial injury in rats with hyperlipidemia. 39(9), 1670-1674. Qian S, L. L., &Fu F et al. (1997). Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction J. Immunol. 158, 4654–4661. RJ, M. R. a. S. (1979). Developmental anatomy and normal structure. In: MacSween RNM, Anthony PP, Scheuer PJ (eds). Pathology of the Liver; New York: Churchill Livingstone. 1–49. Ryan MC, W. A. S. J. e. a. (2005). Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care., 28, 1222-1224. Sallusto F, G. J., Lanzavecchia A. (2004). Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 22, 745–763. Sanyal AJ, B. E., Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A. (2011). Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 54, 344–353. Sanyal AJ, C.-S. C., Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. (2001). Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120, 1183-1192. SC, J. (2012). he legitimate scientific name of the valuable medicinal mushroom ‘Niu-Chang-Chih’ known only from Taiwan Micol Aplicada Int. 24, 43–52. Singh S, A. A., Wang Z& Prokop LJ, Murad MH, Loomba R. (2015). Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol., 13, 643–654. Sumida Y, N. T. Y. T. e. a. ( 2003). Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic liver disease. J Hepatol., 38β, 32–38. Sun Z, K. A., Radaeva S, Hong F, El-Assal O, Pan HN, Jaruga B, Batkai S, Hoshino S, Tian Z, Kunos G&Diehl AM. (2003). In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.Gao B Gastroenterology.Jul., 125(1), 202-215. TahanV R, O. B. C., et al. (2004). Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res. 37(2), 78–84. Teli MR, J. O., Burt AD, Bennett MK, Day CP. (1995). The natural history of non-alcoholic fatty liver: a follow-up study. Hepatology. 22, 1714–1719. Tilg H. (2010). the role of cytokines in non-alcoholic fatty liver disease. Dig Dis. 28(1), 179–185. TiniaKos DG, V. M. B. E. (2010). Nonalcoholic fatty liver disease: pathology and pathogenesis., 5, 145-171. Tokushige K, H. E., Horie Y, Taniai M, Higuchi S. (2011). Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol. 46, 1230–1237. Torer N, O. S., Yucel A, Bukan N, Erdem O. (2007). Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand J Gastroenterol. 42(9), 1095–1101. Torres D.M., W. C. D., Harrison S. (2012). Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol., 10, 837-858. Townsend DM, T. K., Tapiero H. (2003). The importance of glutathione in human disease. Biomedicine and Pharmacotherapy. 57(3), 145–155. Toyoki Y, S. M., Narumi S, Yoshihara S, Morita T, Konn M. (1998). Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline. 45(24), 2261-2264. Tung TH, C. T., Chiu WH, Lin TH, Shih HC, Chang MH, Liu JH. (2011). Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: experience at a teaching hospital. BMC Res Notes. .4, 315 Vernon G, B. A. Y. Z. (2011). Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34, 274-285. Vong CT, T. H., Kwan YW, Lee SM, Hoi MP. (2016). Antrodia camphorata Increases Insulin Secretion and Protects from Apoptosis in MIN6 Cells. Mar. 21.7,67. Wack A, C. P., Harker N, Crispe IN, Kioussis D. (1997). Multiple sites of post-activation CD8+ T cell disposal.Eur J Immunol. 27(3), 577-583. Wang J, H. T., de Guevara LL, Cheung R. (2006). Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C. Wen-Chuan Lin, S.-C. K., Wei-Lii Lin, Hsun-Lang Fang, and Bor-Chen Wang. (2006). Filtrate of fermented mycelia from Antrodia camphorata reduces liver fibrosis induced by carbon tetrachloride in rats. World Journal of Gastroenterology. 12(15), 2369–2374. Wen CL, C. C., Huang SS, Kuo CL, Hsu SLn&Deng JS, Huang GJ. (2011). Anti-inflammatory effects of methanol extract of Antrodia cinnamomea mycelia both in vitro and in vivo. Sep 1,137(1), 575-584. WHO. (2016). World Health Organization Obesity and overweight. Fact sheet No 311. Williams R, G. c. i. l. d. (2006). Hepatology. 44, ,521–526. Wu MT, T. B., Chang YY, Chiu CH, Kang WY, Huang CH, et al. (2011)). Effects ofAntrodia camphorataon alcohol clearance and antifibrosis in livers of rats continuously fed alcohol. J Agric Food Chem. Yamada S, H. C. (1985). Clinical significance of serum hydroxyproline containing peptides with special reference to hyproprotein. Eur J Clin Invest. 13, 129–133. Yaw-Bee Ker , C.-C. P., Wan-Lin Chang, Charng-Cherng Chyau , Robert Y. Peng. (2014). Hepatoprotective Bioactivity of the Glycoprotein, Antrodan, Isolated from Antrodia cinnamomea Mycelia PLOS ONE., 9(4) 93-191. Younossi ZM, G. T. B. B. e. a. ( 1999). Hepatic iron and nonalcoholic fatty liver disease. Hepatology. 30, 847–850. Zhang X, T. S. W. H., et al. ( 2010). Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology. 52, 2137–2147. Zhong JJ, T. Y. F. Q. (2001). Significance of inoculation density control in production of polysaccharides and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochemistry. 37, 1375-1379. 台灣牛樟芝. (2014). 社團法人產業協會. 肖崇厚、陳蘊如. (1989a). 中藥化學。上海科學技術出版社. 肖崇厚、陳蘊如. (1989b). 中藥化學。上海科學技術出版社. 陳勁初, &呂鋒洲. (2001). 靈芝之王台灣樟芝。台北市元氣齋出版社。. 陳勁初, 林文鑫, 陳清農, 許勝傑, 黃仕政, &陳炎鍊. (2001). 臺灣特有真菌樟芝菌絲體之開發菌類科學 (Vol. 16). 陳啟楨. (2009). 主任世界的珍寶牛樟芝。南台科技大學生物科技系所教授兼生物科技研究中心. 陳啟禎. (2002). 樟芝人工栽培與液體發酵萃取物之抗生活性探討 中華民國食品科技學會第三十二次年會年會壁報論文摘要。. Retrieved from 衛生福利部. (105). 統計十大死因統計結果分析. Retrieved from 賴宏亮, 呂美津, 陳武元, &莊秀琪. (2002). 樟芝免疫調節活性之研究。臺灣保健食品學會第二屆第二次年會. Retrieved from 謝孟軒. (2004). 出版刊物高雄市立醫學院肝膽胰科. Retrieved from 顏世榮. (2007). 樟芝降三酸甘油脂之功能研究 台北醫學大學醫學檢驗生物技術學研究所. Retrieved from 譚健民. (2006). 書泉出版社. 譚健民. (2007). 糖尿病性脂肪肝形成的機制亦談脂肪肝的纖維化 臺北市醫師公會會刊。51,43-46。. Retrieved from
|